Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1α in essential hypertension
- 1 February 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 51 (3) , 464-467
- https://doi.org/10.1016/s0002-9149(83)80081-2
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Stability of prostaglandin I2 in human bloodProstaglandins, 1981
- Production of prostacyclin-like substance in stroke-prone and stroke-resistant spontaneously hypertensive ratsProstaglandins, 1979
- Enhanced formation of PGI2, a potent hypotensive substance, by aortic rings and homogenates of the spontaneously hypertensive ratProstaglandins, 1978
- Impaired renal production of prostaglandin E2: A newly identified lesion in human essential hypertensionProstaglandins, 1978
- MODIFICATION OF ANTIHYPERTENSIVE EFFECT OF &bgr;-ADRENOCEPTOR-BLOCKING AGENTS BY INHIBITION OF ENDOGENOUS PROSTAGLANDIN SYNTHESISThe Lancet, 1977
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- On the Formation and Effects of Thromboxane A2 in Human PlateletsActa Physiologica Scandinavica, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Thromboxanes: Selective Biosynthesis and Distinct Biological PropertiesScience, 1976
- Antagonism of the effects of furosemide by in domethacin in normal and hypertensive manProstaglandins, 1975